08/17/2020
3:06 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
3:06 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
2:18 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
2:17 PM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
2:16 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
2:15 PM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
2:14 PM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2020
9:18 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2020
3:13 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2020
2:49 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/14/2020
10:11 AM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2020
4:14 PM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A
| |
05/06/2020
3:05 PM | Clark John Smith II (Reporting)
Fennec Pharmaceuticals (Issuer)
Southpoint Capital Advisors LLC (Reporting)
Southpoint Capital Advisors LP (Reporting)
Southpoint GP, LLC (Reporting)
Southpoint GP, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2020
4:25 PM | Cavazza Enrico (Reporting)
Cavazza Francesca (Reporting)
CAVAZZA PAOLO (Reporting)
Cavazza Preta Martina (Reporting)
Cavazza Silvia (Reporting)
Essetifin SPA (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2020
4:22 PM | Essetifin SPA (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13D/A
| |
05/01/2020
4:28 PM | Fennec Pharmaceuticals (Filer)
| Form 424B5
| |
04/13/2020
4:09 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2020
12:18 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2020
9:28 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2020
1:17 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
10:05 AM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2019
10:04 AM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/12/2019
9:52 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
9:50 AM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/24/2019
2:08 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2019
10:40 AM | Fennec Pharmaceuticals (Issuer)
Goel Shubh (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2019
5:48 PM | Fennec Pharmaceuticals (Issuer)
Goel Shubh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
3:13 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
10:19 AM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
10:15 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2019
1:59 PM | Fennec Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/20/2019
5:03 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
7:34 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2019
7:34 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2019
7:33 PM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2019
7:33 PM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
9:33 AM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A
| |
05/10/2019
8:45 AM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
3:40 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2019
11:35 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2019
3:14 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2019
10:28 AM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2019
10:23 AM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2019
12:27 PM | Fennec Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2019
5:02 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
10:42 AM | 683 Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2019
7:31 AM | Fennec Pharmaceuticals (Subject)
venBio Select Advisor LLC (Filed by)
| Form SC 13G/A
| |
02/04/2019
1:26 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
12:32 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/22/2018
6:46 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4/A
| |
08/21/2018
2:09 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2018
4:26 PM | Fennec Pharmaceuticals (Subject)
MANCHESTER MANAGEMENT PR, LLC (Filed by)
| Form SC 13D/A
| |
08/17/2018
3:33 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2018
1:00 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2018
4:23 PM | Fennec Pharmaceuticals (Subject)
MANCHESTER MANAGEMENT PR, LLC (Filed by)
| Form SC 13D/A
| |
06/22/2018
3:30 PM | Fennec Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
| Form SC 13G
| |
06/11/2018
9:59 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2018
9:54 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2018
9:44 AM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
9:43 AM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
9:41 AM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
9:40 AM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
11:18 AM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2018
4:27 PM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/20/2018
2:14 PM | Fennec Pharmaceuticals (Filer)
| Form 424B3
| |
04/19/2018
11:15 PM | Fennec Pharmaceuticals (Filer)
| Form EFFECT
| |
04/13/2018
5:04 AM | Fennec Pharmaceuticals (Filer)
| Form POS AM
| |
03/29/2018
4:10 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
4:07 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
4:03 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:59 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:55 PM | Fennec Pharmaceuticals (Issuer)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/29/2018
3:51 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:48 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:47 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:45 PM | BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:41 PM | Fennec Pharmaceuticals (Subject)
MANCHESTER MANAGEMENT PR, LLC (Filed by)
| Form SC 13D/A
| |
03/28/2018
4:25 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2018
3:47 PM | Fennec Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/23/2018
2:12 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
10:43 AM | 683 Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/12/2018
3:22 PM | Fennec Pharmaceuticals (Subject)
venBio Select Advisor LLC (Filed by)
| Form SC 13G
| |
02/08/2018
8:03 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2018
8:02 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2017
3:16 PM | Essetifin SPA (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13D
| |
12/14/2017
3:15 PM | Cavazza Enrico (Reporting)
Cavazza Francesca (Reporting)
CAVAZZA PAOLO (Reporting)
Cavazza Preta Martina (Reporting)
Cavazza Silvia (Reporting)
Essetifin SPA (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2017
1:58 PM | Fennec Pharmaceuticals (Filer)
| Form 424B5
| |
12/11/2017
1:51 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2017
3:05 PM | Fennec Pharmaceuticals (Subject)
| Form FWP
| |
12/07/2017
3:05 PM | Fennec Pharmaceuticals (Filer)
| Form 424B5
| |
